Dr. Sana Cough And Chest Congestion Dm Sugar Free Syrup
NDC 53113-515
Product Information
Dr. Sana Cough And Chest Congestion Dm Sugar Free (dextromethorphan hydrobromide, guaifenesin) is a OTC MONOGRAPH DRUG-approved product labeled by Gadal Laboratories, Inc. This medication is typically used as a decreased respiratory secretion viscosity [pe]. It is supplied as a syrup for oral administration. This product entry covers the primary NDC 53113-515 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 53113-515?
What are the uses of this product?
What are Active Ingredients of this product?
- DEXTROMETHORPHAN HYDROBROMIDE 20 mg/30mL - Methyl analog of DEXTRORPHAN that shows high affinity binding to several regions of the brain, including the medullary cough center. This compound is an NMDA receptor antagonist (RECEPTORS, N-METHYL-D-ASPARTATE) and acts as a non-competitive channel blocker. It is one of the widely used ANTITUSSIVES, and is also used to study the involvement of glutamate receptors in neurotoxicity.
- GUAIFENESIN 200 mg/30mL - An expectorant that also has some muscle relaxing action. It is used in many cough preparations.
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- DEXTROMETHORPHAN HYDROBROMIDE (UNII: 9D2RTI9KYH)
- DEXTROMETHORPHAN (UNII: 7355X3ROTS) (Active Moiety)
- GUAIFENESIN (UNII: 495W7451VQ)
- GUAIFENESIN (UNII: 495W7451VQ) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- ALOE VERA LEAF (UNII: ZY81Z83H0X)
- CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)
- CARAMEL (UNII: T9D99G2B1R)
- EUCALYPTUS OIL (UNII: 2R04ONI662)
- GINGER (UNII: C5529G5JPQ)
- GLYCERIN (UNII: PDC6A3C0OX)
- MENTHOL, UNSPECIFIED FORM (UNII: L7T10EIP3A)
- METHYLPARABEN (UNII: A2I8C7HI9T)
- POTASSIUM SORBATE (UNII: 1VPU26JZZ4)
- PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
- PROPYLPARABEN (UNII: Z8IX2SC1OH)
- WATER (UNII: 059QF0KO0R)
- SODIUM BENZOATE (UNII: OJ245FE5EU)
- SUCRALOSE (UNII: 96K6UQ3ZD4)
- XANTHAN GUM (UNII: TTV12P4NEE)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 2719927 - dextromethorphan hydrobromide 20 MG / guaiFENesin 200 MG in 30 mL Oral Suspension
- RxCUI: 2719927 - dextromethorphan hydrobromide 0.667 MG/ML / guaifenesin 6.667 MG/ML Oral Suspension
- RxCUI: 2719927 - dextromethorphan hydrobromide 20 MG / guaifenesin 200 MG per 30 mL Oral Suspension
Which are the Pharmacologic Classes of this product?
- Decreased Respiratory Secretion Viscosity - [PE] (Physiologic Effect)
- Expectorant - [EPC] (Established Pharmacologic Class)
- Increased Respiratory Secretions - [PE] (Physiologic Effect)
- Sigma-1 Agonist - [EPC] (Established Pharmacologic Class)
- Sigma-1 Receptor Agonists - [MoA] (Mechanism of Action)
- Uncompetitive N-methyl-D-aspartate Receptor Antagonist - [EPC] (Established Pharmacologic Class)
- Uncompetitive NMDA Receptor Antagonists - [MoA] (Mechanism of Action)
* Please review the full disclaimer at the bottom of this page.